Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/70975
Title: Latest developments in polypoidal choroidal vasculopathy: Epidemiology, etiology, diagnosis, and treatment
Authors: Voraporn Chaikitmongkol
Chui Ming Gemmy Cheung
Hideki Koizumi
Vishal Govindahar
Jay Chhablani
Timothy Y.Y. Lai
Authors: Voraporn Chaikitmongkol
Chui Ming Gemmy Cheung
Hideki Koizumi
Vishal Govindahar
Jay Chhablani
Timothy Y.Y. Lai
Keywords: Medicine
Issue Date: 1-Jan-2020
Abstract: © 2020 Asia-Pacific Academy of Ophthalmology. All rights reserved. Polypoidal choroidal vasculopathy (PCV) is a condition characterized by multiple, recurrent, serosanguineous pigment epithelial detachments, and neurosensory retinal detachments due to abnormal aneurysmal neovascular lesions. It is generally considered as a variant of neovascular age-related macular degeneration, but there are some differences between the clinical presentation, natural history, and treatment response between patients with PCV and typical neovascular age-related macular degeneration patients. Over the past decade, new research and technological advancements have greatly improved our understanding of the PCV disease process and the management of PCV. This review aims to summarize the recent research findings to highlight the epidemiology, pathogenesis, genetics, the application of various diagnostic tools for PCV, and the available treatment options for PCV.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086285570&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/70975
ISSN: 21620989
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.